Ftse Mib
37.977,59
0,18%
DAX
22.513,42
-0,43%
S&P 500
6.114,63
-0,01%
NASDAQ
20.026,77
0,41%
Bitcoin
97.736,25
0,22%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Soleno Therapeutics Inc (SLNO) Soleno Therapeutics Inc (SLNO) Notizie

Soleno Therapeutics Inc

SLNO
49,17
-2,16 (-4,21%)
15 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/2/202523:28EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
29/1/202522:05GLOBESoleno Therapeutics to Participate in Upcoming February..
24/1/202523:01EDGAR2Form 8-K - Current report
23/1/202522:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202522:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202522:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202522:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202522:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202503:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202503:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202503:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202422:30EDGAR2Form 8-K - Current report
17/12/202422:05GLOBESoleno Therapeutics Enters Into $200 Million Debt Financing..
27/11/202414:00GLOBESoleno Therapeutics to Participate in Piper Sandler 36th..
26/11/202414:46EDGAR2Form 8-K - Current report
26/11/202414:30GLOBESoleno Therapeutics Announces FDA Extension of Review Period..
14/11/202422:05GLOBESoleno Therapeutics Announces Oral Presentations featuring..
14/11/202415:36EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
12/11/202415:33EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
06/11/202422:17EDGAR2Form 8-K - Current report
06/11/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:05GLOBESoleno Therapeutics Provides Corporate Update and Reports..
28/10/202413:00GLOBESoleno Therapeutics to Participate in Upcoming November..
24/10/202422:44EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
21/10/202422:31EDGAR2Form SC 13D/A - General Statement of Acquisition of..
21/10/202422:30EDGAR2Form 144 - Report of proposed sale of securities
21/10/202414:00GLOBESoleno Therapeutics Announces the Passing of Former Chairman..
15/10/202422:31EDGAR2Form SC 13D/A - General Statement of Acquisition of..
10/10/202422:30EDGAR2Form SC 13D/A - General Statement of Acquisition of..
08/10/202414:30GLOBESoleno Therapeutics Announces Regulatory Update on DCCR..
04/10/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202423:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202423:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202422:05GLOBESoleno Therapeutics to Present at 2024 Cantor Global..
11/9/202400:30EDGAR2Form SC 13D/A - General Statement of Acquisition of..
06/9/202400:37EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
31/8/202400:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202400:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202400:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202401:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/8/202414:00GLOBESoleno Therapeutics Announces U.S. FDA Acceptance for Filing..
24/8/202401:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202401:14EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/8/202422:17GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
17/8/202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202400:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/8/202422:06EDGAR2Form 8-K - Current report
15/8/202414:00GLOBESoleno Therapeutics Announces Updates to its Board of..
08/8/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 51,54 Min: 48,285 Max: 52,46
Chiusura: 51,33

La tua Cronologia

NASDAQ
SLNO
Soleno Therapeutics
BIT
UC20T6
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci